|
|
TIP 40: Clinical Guidelines for the Use of Buprenorpnine in the Treatment of Opioid Addiction
Clinical Guidelines for the Use of Buprenorphine in the Treatment of Opioid Addiction, SAMHSA's Treatment Improvement Protocol 40 (TIP 40), provides the basis for training thousands of physicians in the United States to use buprenorphine to treat patients addicted to heroin or to prescription pain medications such as oxycodone, hydrocodone, or meperidine. The TIP covers screening, assessment, and diagnosis of opioid dependence and its associated problems. In addition, the TIP includes information on how to determine when buprenorphine is an appropriate treatment option and when to make referrals to treatment counselors. Other information explains how patients can benefit from participating in self-help programs.
https://ncadistore.samhsa.gov/catalog/productDetails.aspx?ProductID=16829
Publisher SAMHSA's National Clearinghouse on Alcohol and Drug Information (NCADI) 11420 Rockville Pike Rockville, md 20852 Phone: 800-729-6686 Website: http://www.ncadi.samhsa.gov
|
|
|
Boston University School of Public Health 
